🌐 The existing analytical workflow in biomanufacturing has blind spots and bottlenecks, leading to delays and increased costs. ⏱️
💡 Atlas uses tunable laser spectroscopy to analyze buffer excipients and high concentration proteins in just one minute. 🚀
🔬 This system provides accurate data at the point of sampling, eliminating the need for retrospective analysis. 💯
📈 Early adopter studies have shown the potential of Atlas in studying and optimizing protein formulations. 📊
🌟 Atlas is the first step towards real-time monitoring and integrated control in bioprocessing, according to Nirrin Technologies. 💪
Introduction:
Nirrin Technologies has introduced the Atlas™ system, which enables at-line excipient and product titer quantitation in downstream bioprocessing applications. This system aims to address the blind spots and bottlenecks in the existing analytical workflow for biomanufacturing, which often result in increased time to market and manufacturing costs for critical drugs.
- The existing analytical workflow for biomanufacturing suffers from blind spots and bottlenecks, leading to increased time to market and manufacturing costs.
- The Atlas™ system, powered by tunable laser spectroscopy™ (HPTLS) technology, allows for simultaneous analysis of buffer excipients and high concentration proteins in one minute throughout the bioprocess.
- Early adopter studies have shown the potential of Atlas™ in overcoming the limitations of traditional analysis techniques and optimizing protein formulations.
- Atlas™ provides real-time, accurate data, eliminating the need to wait for retrospective data from a core lab.
- The system has the potential to enable continuous monitoring and control of bioprocesses and can deliver cost-effective, actionable insights.
Conclusion:
The introduction of the Atlas™ system by Nirrin Technologies addresses the challenges and limitations of the existing analytical workflow in biomanufacturing. By providing real-time, accurate data at the point of sampling, this system has the potential to improve process control, reduce time to market, and optimize manufacturing costs in the biopharmaceutical industry.
